In the News

Share
Print
1938 News Items found
Charles Rudin and Dana Pe'er
Molecular Atlas of Small Cell Lung Cancer Reveals Unusual Cell Type That Could Explain Why It’s So Aggressive
Stem-like cells that make up only a tiny fraction of the total cells in a lung tumor could be the key to stopping the disease’s deadly spread, say researchers at Memorial Sloan Kettering.
Cesar Figueroa Ortiz posing for a photo with his parents
Home at Last: Cesar Figueroa Ortiz
Meet Cesar Figueroa Ortiz, who says, “The mission of MSK really resonated with me, all the employees seemed very happy, and the patients said great things about their care.”
Ask the Expert
Memorial Sloan Kettering surgeon Andrea Barrio
What Is Ductal Carcinoma In Situ (DCIS), and How Do I Decide on the Right Treatment?
Learn about the breast cancer type called ductal carcinoma in situ (DCIS) and how doctors decide on the best treatment for each person.
GSK student in lab
How an Innovative Biomedical Graduate School Empowers Students to Reach Their Potential
Hear from GSK Alumni Lindsey, Prashant, and Theresa, as they share more about their experience and where their careers have taken them.
In the Lab
Physician-scientist Piro Lito
Researchers Uncover New Findings about KRAS, an Important Protein in Cancer
Researchers have taken a closer look at what a protein called KRAS does in normal cells and how certain KRAS mutations lead to for cancer growth.
memorial sloan kettering patient katie gay
Missed a Mammogram During COVID-19? Here’s Why You Need to Reschedule As Soon As Possible
Find out why you still need your routine mammogram, even during COVID-19.
Justin Perry, PhD
Sloan Kettering Institute’s Justin Perry Honored with Distinguished NIH Director’s New Innovator Award
Justin Perry, PhD, cell biologist and immunologist of Memorial Sloan Kettering’s (MSK) Sloan Kettering Institute (SKI) has been named a recipient of the 2021 National Institutes of Health (NIH) Director’s New Innovator Award.
Katharine Hsu and Rosa Sottile
Unusual Immune Cell Type Could Be Good Target for Immunotherapy
Part natural killer, part T cell, this hybrid immune cell has a “double sword” for fighting cancer.
fruits and vegetables
Food as Medicine: How MSK Is Helping Latinx Cancer Patients Eat Right
Discover how Memorial Sloan Kettering is teaming up with local hospitals to promote healthy eating in the Latinx community.
Breast cancer patient Mikaela Rix
Mikaela’s Story: Facing Breast Cancer as a Woman in Her 20s
Former college lacrosse player Mikaela Rix, diagnosed at age 26, accessed a wide range of resources offered by MSK’s new program tailored for young women with breast cancer.